BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 9816132)

  • 1. Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?
    Humayun-Zakaria N; Ward DG; Arnold R; Bryan RT
    Transl Androl Urol; 2021 Jun; 10(6):2787-2808. PubMed ID: 34295762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and survival outcomes of metachronous contralateral upper tract urothelial carcinoma.
    Wu K; Liang J; Lu Y
    Sci Rep; 2020 Oct; 10(1):16600. PubMed ID: 33024233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder.
    Wang Y; Lang MR; Pin CL; Izawa JI
    Springerplus; 2013; 2():412. PubMed ID: 24024098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumors of the urinary system. Current and old problems].
    Minner S; Sauter G
    Pathologe; 2009 Dec; 30 Suppl 2():179-84. PubMed ID: 19960299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer.
    Phillips HA; Howard GC; Miller WR
    Br J Cancer; 2000 Jan; 82(1):136-41. PubMed ID: 10638980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic monoclonality in multifocal uroepithelial carcinomas: evidence of intraluminal tumour seeding.
    Fadl-Elmula I; Gorunova L; Mandahl N; Elfving P; Lundgren R; Mitelman F; Heim S
    Br J Cancer; 1999 Sep; 81(1):6-12. PubMed ID: 10487605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [p53 and prognosis of urothelial bladder tumors].
    Chopin D
    Pathol Biol (Paris); 1997 Dec; 45(10):893-7. PubMed ID: 9769954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression in transitional cell carcinoma of the urinary bladder--analysis of Tp53 gene mutations by temperature gradients and sequence in tumor tissues and in cellular urine sediments.
    Schlechte HH; Sachs MD; Lenk SV; Brenner S; Rudolph BD; Loening SA
    Cancer Detect Prev; 2000; 24(1):24-32. PubMed ID: 10757120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.
    Curigliano G; Ferretti G; Flamini G; Goldhirsch A; de Braud F; Calabro MG; Mandaly M; Nole F; De Pas T; D'Addessi A; Cittadini A
    Anticancer Res; 2001; 21(4B):3015-20. PubMed ID: 11712804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident.
    Yamamoto S; Romanenko A; Wei M; Masuda C; Zaparin W; Vinnichenko W; Vozianov A; Lee CC; Morimura K; Wanibuchi H; Tada M; Fukushima S
    Cancer Res; 1999 Aug; 59(15):3606-9. PubMed ID: 10446970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
    Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers.
    Xu X; Stower MJ; Reid IN; Garner RC; Burns PA
    Clin Cancer Res; 1996 Oct; 2(10):1795-800. PubMed ID: 9816132
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.